SMMT
Summit Therapeutics PLC
16.40$
-0.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,720.2% | -95.5% | -26.5% | -3.4% | +15.2% | +10.1% | +61.2% | +34.5% | -25.8% | +7.0% | -21,466.5% | – | |
| – | +1,095.3% | +9.3% | +15.7% | +68.7% | -40.4% | -2.4% | +1,031.0% | +34.5% | -36.6% | -33.5% | +56.3% | – | |
| – | +91.6% | -49.2% | -29.2% | +189.0% | -108.0% | – | – | +34.5% | -21.3% | -120.5% | – | – | |
| – | -96.4% | +101.4% | +1,461.9% | -11.1% | -74.7% | +2,821.8% | -83.9% | +34.5% | +71.4% | +52.7% | +421.1% | – | |
| – | – | -67.0% | -1,098.5% | -47.6% | – | +85.9% | -100.0% | – | – | -99.9% | – | – | |
| – | – | – | – | – | -67.5% | – | – | – | – | – | – | – | |
| – | +2,528.4% | -92.2% | +40,836.8% | -1.5% | -112.1% | – | +322.7% | +34.5% | +1,159.5% | -99.3% | +15,754.5% | – | |
| – | – | -120.7% | – | – | -82.2% | +832.3% | -153.4% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.